The Tencent, China Electronics Corporation, Sinopharm and Sunshine Insurance-backed healthcare efficiency software provider raised $77.2m in the round.

Synyi AI, a China-based medical software developer backed by corporates Tencent, China Electronics Corporation, Sinopharm and Sunshine Insurance, has raised RMB500m ($77.2m) in series E funding, DealStreetAsia reported on Friday.

The round was led by venture capital group IDG Capital, which was joined by Longmen Investments and Sharewin Investment.

Founded in 2016, Synyi supplies artificial intelligence-equipped software used by healthcare providers and clinical researchers to improve the efficiency of their operations. It has served more than 150 hospitals in China.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?